Inactive Instrument

Insiders Senesco Technologies, Inc. Nyse

Equities

US8172084084

End-of-day quote Nyse Other stock markets
- ^USD	-

04-11	North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	DJ
03-13	Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eloxx Pharmaceuticals, Inc. Announces Resignation of Tomer Kariv from the Board	12-28	CI
Eloxx Pharmaceuticals, Inc. Announces Resignation of Vijay Modur as Head of Research and Development	15/09/23	CI
Eloxx Pharmaceuticals, Inc. Announces Committee Changes	05/07/22	CI
Eloxx Pharmaceuticals Announces Changes to Board of Directors	05/07/22	CI
Eloxx Pharmaceuticals, Inc. Appoints Ali Hariri as Chief Medical Officer	09/11/21	CI
Eloxx Pharmaceuticals, Inc. Appoints Ali Hariri as Chief Medical Officer	08/09/21	CI
Eloxx Pharmaceuticals, Inc. Appoints Daniel Geffken as Principal Accounting Officer	20/08/21	CI
Gary Rakers to Resign as Executive Director, Finance & Accounting, Corporate Conroller and Treasurer of Eloxx Pharmaceuticals, Inc, Effective July 30, 2021	16/07/21	CI
Eloxx Pharmaceuticals, Inc. Announces the departure of Neil Belloff as Chief Operating Officer and General Counsel, Effective August 25, 2021	06/07/21	CI
Eloxx Pharmaceuticals, Inc. Announces Executive Changes	01/04/21	CI
Eloxx Pharmaceuticals, Inc. Announces Change of CEO	01/04/21	CI
Eloxx Pharmaceuticals, Inc. Appoints Daniel Geffken as Interim Chief Financial Officer	01/04/21	CI
Eloxx Pharmaceuticals, Inc. Announces Board Changes	26/03/21	CI
Eloxx Pharmaceuticals, Inc. Announces Resignation of Stephen Macdonald as Vice President, Finance and Accounting, and Treasurer (Principal Financial and Accounting Officer) Effective March 26, 2021	12/03/21	CI
Eloxx Pharmaceuticals, Inc. Announces Appointment of Eitan Kerem as Senior Consultant	14/09/20	CI
Eloxx Pharmaceuticals, Inc. Announces Executive Changes; Announces Organizational Re-Alignment	26/02/20	CI
Eloxx Pharmaceuticals, Inc. Hires Susan Schneider as Senior Vice President Ophthalmology	08/03/19	CI
Pedro Huertas Intention to Resign as Chief Medical Officer of Eloxx Pharmaceuticals, Inc	03/08/18	CI
Eloxx Pharmaceuticals, Inc. Announces Executive Appointments	25/06/18	CI
Eloxx Pharmaceuticals, Inc. Appoints Neil Belloff as Executive Vice President, General Counsel and Corporate Secretary	18/06/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Senesco Technologies, Inc. Nyse

Equities

US8172084084

Insiders

Filters